Cargando…
The Added Value of High Dose Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome after Conversion from Standard Spinal Cord Stimulation
Patients with Failed Back Surgery Syndrome (FBSS) report a considerably lower health- related quality of life (HRQoL), compared to the general population. Spinal cord stimulation (SCS) is an effective treatment to offer pain relief in those patients. Despite initial treatment success of SCS, its eff...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601014/ https://www.ncbi.nlm.nih.gov/pubmed/32992612 http://dx.doi.org/10.3390/jcm9103126 |
_version_ | 1783603296833896448 |
---|---|
author | De Jaeger, Mats Goudman, Lisa Putman, Koen De Smedt, Ann Rigoard, Philippe Geens, Wietse Moens, Maarten |
author_facet | De Jaeger, Mats Goudman, Lisa Putman, Koen De Smedt, Ann Rigoard, Philippe Geens, Wietse Moens, Maarten |
author_sort | De Jaeger, Mats |
collection | PubMed |
description | Patients with Failed Back Surgery Syndrome (FBSS) report a considerably lower health- related quality of life (HRQoL), compared to the general population. Spinal cord stimulation (SCS) is an effective treatment to offer pain relief in those patients. Despite initial treatment success of SCS, its effect sometimes wears off over time. This study investigates the added value of high dose SCS (HD-SCS) in patients with unsatisfactory conventional SCS, from a quality of life perspective. Seventy-eight FBSS patients who were treated with conventional SCS that failed to provide pain relief, were recruited in 15 centers. HRQoL was assessed before converting to HD-SCS (baseline) and three times after converting to HD-SCS using the EuroQol-5D-3L. Quality adjusted life years (QALY) were calculated and compared with conventional SCS. An overall significant increase over time was seen in utility values of the EQ5D-3L, as the mean value at baseline 0.283 (±0.21) increased to 0.452 (±0.29) at 12 months of HD-SCS. This average increase in utility coincides with an average increase of 0.153 (±0.24) QALY’s in comparison to continued conventional SCS. Besides the potential of HD-SCS to salvage patients with failed responses to conventional SCS, this treatment seems to be a more efficient treatment than conventional SCS. |
format | Online Article Text |
id | pubmed-7601014 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76010142020-11-01 The Added Value of High Dose Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome after Conversion from Standard Spinal Cord Stimulation De Jaeger, Mats Goudman, Lisa Putman, Koen De Smedt, Ann Rigoard, Philippe Geens, Wietse Moens, Maarten J Clin Med Article Patients with Failed Back Surgery Syndrome (FBSS) report a considerably lower health- related quality of life (HRQoL), compared to the general population. Spinal cord stimulation (SCS) is an effective treatment to offer pain relief in those patients. Despite initial treatment success of SCS, its effect sometimes wears off over time. This study investigates the added value of high dose SCS (HD-SCS) in patients with unsatisfactory conventional SCS, from a quality of life perspective. Seventy-eight FBSS patients who were treated with conventional SCS that failed to provide pain relief, were recruited in 15 centers. HRQoL was assessed before converting to HD-SCS (baseline) and three times after converting to HD-SCS using the EuroQol-5D-3L. Quality adjusted life years (QALY) were calculated and compared with conventional SCS. An overall significant increase over time was seen in utility values of the EQ5D-3L, as the mean value at baseline 0.283 (±0.21) increased to 0.452 (±0.29) at 12 months of HD-SCS. This average increase in utility coincides with an average increase of 0.153 (±0.24) QALY’s in comparison to continued conventional SCS. Besides the potential of HD-SCS to salvage patients with failed responses to conventional SCS, this treatment seems to be a more efficient treatment than conventional SCS. MDPI 2020-09-27 /pmc/articles/PMC7601014/ /pubmed/32992612 http://dx.doi.org/10.3390/jcm9103126 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article De Jaeger, Mats Goudman, Lisa Putman, Koen De Smedt, Ann Rigoard, Philippe Geens, Wietse Moens, Maarten The Added Value of High Dose Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome after Conversion from Standard Spinal Cord Stimulation |
title | The Added Value of High Dose Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome after Conversion from Standard Spinal Cord Stimulation |
title_full | The Added Value of High Dose Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome after Conversion from Standard Spinal Cord Stimulation |
title_fullStr | The Added Value of High Dose Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome after Conversion from Standard Spinal Cord Stimulation |
title_full_unstemmed | The Added Value of High Dose Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome after Conversion from Standard Spinal Cord Stimulation |
title_short | The Added Value of High Dose Spinal Cord Stimulation in Patients with Failed Back Surgery Syndrome after Conversion from Standard Spinal Cord Stimulation |
title_sort | added value of high dose spinal cord stimulation in patients with failed back surgery syndrome after conversion from standard spinal cord stimulation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7601014/ https://www.ncbi.nlm.nih.gov/pubmed/32992612 http://dx.doi.org/10.3390/jcm9103126 |
work_keys_str_mv | AT dejaegermats theaddedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT goudmanlisa theaddedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT putmankoen theaddedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT desmedtann theaddedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT rigoardphilippe theaddedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT geenswietse theaddedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT moensmaarten theaddedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT dejaegermats addedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT goudmanlisa addedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT putmankoen addedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT desmedtann addedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT rigoardphilippe addedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT geenswietse addedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation AT moensmaarten addedvalueofhighdosespinalcordstimulationinpatientswithfailedbacksurgerysyndromeafterconversionfromstandardspinalcordstimulation |